Circulation

NOVEMBER 11, 2024

Introduction:Blood pressure targets for the elderly are still controversial, there is a lack of certainty about the benefit and safety of targeting ≤ 130mmHg systolic blood pressure. of patients had cardiovascular disease, 10.9% chronic kidney disease. diabetes, and 15.5% and I2 = 0%, p = 0.44).

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Stroke: Vascular and Interventional Neurology

MARCH 6, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDHypertension is often codiagnosed in patients with moyamoya disease (MMD), a progressive intracranial steno‐occlusive vasculopathy; this has principally been attributed to renal artery stenosis (up to 10%). 6.04]), kidney disease (OR, 18.98 [95% CI, 1.80–200.47]),

Hypertension 40

Hypertension Blood Pressure Pediatrics Kidney Disease 40

DAIC

DECEMBER 8, 2023

AFib causes a variety of symptoms, including fast or chaotic heartbeat, fatigue, shortness of breath, and chest pain, and causes about 450,000 hospitalizations each year, according to the Centers for Disease Control and Prevention. For example, kidney disease is not included in CHA 2 DS 2 -VASc.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Strokes Stroke 52

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among Results:Among 5002 (projected to 34.0

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrial fibrillation (AF) patients.

Atrial Fibrillation 40

Atrial Fibrillation Hemorrhage Risk Factors Kidney Disease 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionAtherosclerosis, the hardening and narrowing of the arteries, occurs due to the buildup of plaque on the inner walls of the arteries which can result in reduced blood flow to the organs and tissues.

Risk Factors 40

Risk Factors Blood Pressure Chest Pain Plaque 40

MIBHS

JUNE 14, 2024

Excessive salt intake has been linked to a range of health concerns, including high blood pressure, heart disease, stroke, and kidney problems. In efforts to reduce salt, you also reduce your risk for a number of diseases and conditions.

Diet 40

Diet Kidney Disease Blood Pressure Heart Disease 40

DAIC

APRIL 7, 2024

Akshay Desai, MD “Compared to placebo, a single injection of zilebesiran resulted in clinically meaningful reductions in blood pressure at three months when added to commonly used antihypertensive treatments,” said Akshay Desai, MD, MPH , a cardiologist at Brigham and Women’s Hospital in Boston and a study coauthor. “In

Blood Pressure 111

Blood Pressure Heart Attack Heart attacks Hypertension 111

Dr. Paddy Barrett

JULY 5, 2024

We do a terrible job of identifying and managing high blood pressure. And we still do an awful job of identifying and managing high blood pressure. As a risk factor for death, high blood pressure is responsible for more deaths than any other risk factor, including smoking. What Is Normal Blood Pressure?

Blood Pressure 105

Blood Pressure Heart Attack Heart attacks Risk Factors 105

Open Heart

DECEMBER 23, 2024

Background Hypertension is a risk factor for bleeding events and is included in the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/Alcohol concomitantly) score.

Blood Pressure 40

Blood Pressure Peripheral Arterial Disease Kidney Disease Laboratory 40

DAIC

JANUARY 19, 2024

AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce blood pressure. This leaves a gap in the care of these patients and increases their risk for heart attack, stroke and heart failure progression.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A102-A102, February 1, 2025. Background and Purpose:Chronic kidney disease (CKD) is associated with an increased risk of stroke and worse outcomes, yet it is often asymptomatic, with an estimated 90% of individuals unaware they have CKD until its later stages. female, 22.1%

Atherosclerosis 40

Atherosclerosis Kidney Disease Blood Pressure Biomarkers 40

Circulation

NOVEMBER 11, 2024

Background:Empagliflozin is a sodium glucose co-transporter 2 inhibitor that improves cardiovascular outcomes in patients with type 2 diabetes mellitus, chronic kidney disease and heart failure. Circulation, Volume 150, Issue Suppl_1 , Page A4121215-A4121215, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Heart Failure Kidney Disease 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Cardiometabolic Health Congress

JULY 25, 2023

17] Glycemic improvement alone, however, has not been associated with improved risk of macrovascular diabetes complications, such as myocardial infarction, stroke and heart failure. So, if a patient is concerned about their weight or blood pressure, treatment needs to be individualized accordingly. [26]

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heart failure (HF), chronic kidney disease (CKD), and peripheral artery disease (PAD). million.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Strokes 111

DAIC

APRIL 17, 2025

Previous research indicates the rate ofischemic(clot-caused) stroke among adults 18-49 years old is increasing and propelled by a corresponding rise incryptogenicstrokes (strokes of unknown cause) in adults without traditional risk factors, including high blood pressure, smoking, obesity, high cholesterol andType 2 diabetes.

Risk Factors 52

Risk Factors Strokes Stroke Blood Pressure 52